Poster

Role of Ki67 expression as a prognostic marker in advanced colorectal cancer

BackgroundColorectal cancer (CRC) is one of the most frequent malignancies and the third cause of death from cancer globally. To increase prognosis prediction in patients with CRC, unders...

06/25/2023

Validation study of a high-performance whole-blood assay for the detection of colorectal advanced adenomas in average risk population

BackgroundThe benefits of CRC screening are limited by low compliance of colonoscopy and stool-based screening methods, resulting in one in three eligible adults not up to date with scree...

06/25/2023

The promising role of TGF-βRII mutations and EGFR immunostaining in response to anti-EGFR therapies

BackgroundIn sporadic colorectal cancer, the presence of mutations in the RAS genes means a lack of response to anti-EGFR drugs, while the absence of mutations in these genes does not gua...

06/25/2023

Induction chemotherapy followed by response evaluation and esophagectomy for advanced esophageal cancer

BackgroundPatients with extensive locoregional and/or oligometastatic esophageal cancer have a poor prognosis and are often referred for palliative care. However, induction chemotherapy f...

06/25/2023

Epidemiological, clinical and therapeutic profile of gastric cancer

BackgroundGastric cancer is common in men with 65% of patients being male. It is the second digestive cancer after colorectal cancer and the second cause of death by digestive cancer, the...

06/25/2023

Novel data visualization and unsupervised machine learning techniques to support optimal management of toxicity profiles of encorafenib plus cetuximab in patients with BRAFV600E-mutant metastatic colorectal cancer

BackgroundThe BRAF inhibitor encorafenib, in combination with cetuximab (EC), has recently been approved for patients with BRAFV600E-mutated metastatic colorectal cancer (BRAFV600E-mCRC) ...

06/25/2023

Rechallenge with anti-EGFR antibodies in metastatic colorectal cancer: A single center analysis

BackgroundColorectal cancer remains the third most common cancer, and its management has been dramatically affected by the advent of molecular profiling. Anti-epidermal growth factor rece...

06/25/2023

Impact of the curative treatment of colorectal liver metastases

BackgroundLocal and systemic treatments of colorectal liver metastases can improve survival and be curative. We aimed in our study to evaluate survival outcomes of liver treatment and to ...

06/25/2023

Exploring the prognostic value in methylation markers in early detection of hepatocellular carcinoma

BackgroundHepatocellular carcinoma (HCC) has an unfavourable prognosis with little difference between incidence and mortality due to late detection. Unfortunately, despite an established ...

06/25/2023

Micronutrient insufficiency after surgery for oesophagogastric neoplasms: A prospective intervention study VITAMin Insufficiency in oesophagogastric Neoplasms or the VITAMIN study

BackgroundOesophageal and gastric cancer are among the top ten cancers worldwide. Both diseases have major impact on the nutritional status and quality of life (QoL). Preoperative malnutr...

06/25/2023